Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | TDO2 | P48775 | 2/20 | 0.40 |
| ▸ | IDO2 | Q6ZQW0 | 2/20 | 0.40 |
| ▸ | IGFBP3 | P17936 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
| ▸ | FABP4 | P15090 | 1/20 | 0.37 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.37 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.37 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.37 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5112227 | 1.00 | MEN1 (0.46) | MEN1KMT2AACP3CES2CES1 | |
| SCHEMBL8128086 | 1.00 | MEN1 (0.46) | MEN1KMT2AACP3CES2CES1 | |
| Parachlorophenol SCHEMBL9107453 | 0.88 | MAPK1 (0.42) | MEN1KMT2AACP3CES2CES1 | |
| SCHEMBL4596673 | 0.87 | KMT2A (0.42) | MEN1KMT2AACP3ALDH1A1CXCL8 | |
| SCHEMBL16161639 | 0.84 | TSHR (0.50) | MEN1KMT2AACP3ALDH1A1CXCL8 | |
| SCHEMBL9297918 | 0.83 | ACP3 (0.42) | MEN1KMT2AACP3CES2CES1 | |
| SCHEMBL9297917 | 0.83 | ACP3 (0.42) | MEN1KMT2AACP3CES2CES1 | |
| SCHEMBL8797718 | 0.82 | MEN1 (0.46) | MEN1KMT2AACP3CES2CES1 | |
| SCHEMBL15485148 | 0.82 | KMT2A (0.43) | MEN1KMT2ACES2CES1ALDH1A1 | |
| Metacresol SCHEMBL9102481 | 0.82 | ACHE (0.47) | MEN1KMT2AALDH1A1CXCL8IGFBP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108201934-B | Stone grinding device for engineering and working method thereof | XUZHOU INSTITUTE OF TECHNOLOGY (CN) | 2019-12-10 | — | — | CN | claimed |
| WO-2012007019-A1 | PROCESS FOR THE PREPARATION OF CLOPIDOGREL AND SALTS THEREOF | PHARMATHEN S.A. (GR) | 2012-01-19 | — | — | WO | claimed |
| EP-1907397-B1 | METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN | HANMI HOLDINGS CO LTD (KR) | 2011-06-29 | — | — | EP | claimed |
| US-7652140-B2 | Method of preparing clopidogrel and intermediates used therein | HANMI PHARM. CO., LTD (KR) | 2010-01-26 | — | — | US | claimed |
| EP-1907397-A4 | METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN | HANMI PHARM IND CO LTD (KR) | 2009-05-27 | — | — | EP | claimed |
| US-20080214821-A1 | Method of Preparing Clopidogrel and Intermediates Used Therein | HANMI PHARM., CO., LTD. (KR) | 2008-09-04 | — | — | US | claimed |
| EP-1907397-A1 | METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN | Hanmi Pharm. Co., Ltd. (KR) | 2008-04-09 | — | — | EP | claimed |
| WO-2007126258-A1 | THE METHOD OF MAKING OPTICALLY ACTIVE 2-HALO-2-(N-SUBSTITUTED PHENYL)ACETIC ACID ESTERS AND 2-HALO-2-(N-SUBSTITUTED PHENYL)ACETIC ACIDS BY ENZYMATIC METHOD | ENZYTECH, LTD (KR) | 2007-11-08 | — | — | WO | claimed |
| WO-2006137628-A1 | METHOD OF PREPARING CLOPIDOGREL AND INTERMEDIATES USED THEREIN | HANMI PHARM. CO., LTD. (KR) | 2006-12-28 | — | — | WO | claimed |
| EP-0420706-B1 | Process for preparing phenylacetic derivatives of thienopyridines and intermediates alpha-bromo-phenylacetic acids | SANOFI SA (FR) | 1995-10-11 | — | — | EP | claimed |
| US-5189170-A | Process for the preparation of phenylacetic derivatives of thieno-pyridines | SANOFI (FR) | 1993-02-23 | — | — | US | claimed |
| CN-115160340-A | Small molecule compound with ACK1 inhibitory activity and application thereof | 四川大学华西医院 | 2022-10-11 | — | — | CN | disclosed |
| US-11202774-B2 | 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents | JIVA PHARMA INC. (US) | 2021-12-21 | — | — | US | disclosed |
| CN-111606923-B | Synthesis method of racemic clopidogrel | 武汉理工大学 | 2021-08-24 | — | — | CN | disclosed |
| CN-106928251-B | Preparation method of high-purity clopidogrel | 江苏天士力帝益药业有限公司 | 2021-05-04 | — | — | CN | disclosed |
| US-5036156-A | Bromination, hydrolysis | SANOFI (FR) | 1991-07-30 | — | — | US | disclosed |
| US-4275065-A | USEFUL FOR SKIN GRAFTS AND ORGAN TRANSPLANTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-06-23 | — | — | US | disclosed |
| EP-0021773-A1 | Thiazolo (2,3-b) benzo (and azabenzo) thiazole derivatives, process for their preparation and pharmaceutical compositions containing them | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4053626-A | CHOLESTEROL LEVEL-LOWERING PHENOXYACETIC ACIDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-10-11 | — | — | US | disclosed |
| US-3992386-A | 4(Quinolyl)phenoxy alkanoic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214821-A1 | Method of Preparing Clopidogrel and Intermediates Used Therein | P2RY11, PTGIS, PTGIR | MEN1 2819/4885KMT2A 3115/4885ACP3 2554/4885 |
| US-11202774-B2 | 5-substituted 2,4-thiazolidinediones (thiohydantoins), pseudothiohydantoins, and propseudothiohydantoins for use as antiviral agents | DPP4, TPMT, DPP7 | MEN1 643/4885KMT2A 1919/4885ACP3 4322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.